Anti-PXDC1 monoclonal antibody

Pre-made anti-PXDC1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to PXDC1/PXDC1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2684-Ab-1/ GM-Tg-hg-IP2684-Ab-2Anti-Human PXDC1 monoclonal antibodyHuman
GM-Tg-rg-IP2684-Ab-1/ GM-Tg-rg-IP2684-Ab-2Anti-Rat PXDC1 monoclonal antibodyRat
GM-Tg-mg-IP2684-Ab-1/ GM-Tg-mg-IP2684-Ab-2Anti-Mouse PXDC1 monoclonal antibodyMouse
GM-Tg-cynog-IP2684-Ab-1/ GM-Tg-cynog-IP2684-Ab-2Anti-Cynomolgus/ Rhesus macaque PXDC1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2684-Ab-1/ GM-Tg-felg-IP2684-Ab-2Anti-Feline PXDC1 monoclonal antibodyFeline
GM-Tg-cang-IP2684-Ab-1/ GM-Tg-cang-IP2684-Ab-2Anti-Canine PXDC1 monoclonal antibodyCanine
GM-Tg-bovg-IP2684-Ab-1/ GM-Tg-bovg-IP2684-Ab-2Anti-Bovine PXDC1 monoclonal antibodyBovine
GM-Tg-equg-IP2684-Ab-1/ GM-Tg-equg-IP2684-Ab-2Anti-Equine PXDC1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2684-Ab-1/ GM-Tg-hg-IP2684-Ab-2; GM-Tg-rg-IP2684-Ab-1/ GM-Tg-rg-IP2684-Ab-2;
GM-Tg-mg-IP2684-Ab-1/ GM-Tg-mg-IP2684-Ab-2; GM-Tg-cynog-IP2684-Ab-1/ GM-Tg-cynog-IP2684-Ab-2;
GM-Tg-felg-IP2684-Ab-1/ GM-Tg-felg-IP2684-Ab-2; GM-Tg-cang-IP2684-Ab-1/ GM-Tg-cang-IP2684-Ab-2;
GM-Tg-bovg-IP2684-Ab-1/ GM-Tg-bovg-IP2684-Ab-2; GM-Tg-equg-IP2684-Ab-1/ GM-Tg-equg-IP2684-Ab-2
Products NameAnti-PXDC1 monoclonal antibody
Formatmab
Target NamePXDC1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-PXDC1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2684-Ag-1Recombinant multi-species PXDC1/ C6orf145 protein
    ORF Viral VectorvGMLP004656human PXDC1 Lentivirus particle
    ORF Viral VectorpGMLP004656human PXDC1 Lentivirus plasmid
    ORF Viral VectorpGMAD000535Norway rat Pxdc1 Adenovirus plasmid
    ORF Viral VectorpGMLPm001292mouse Pxdc1 Lentivirus plasmid
    ORF Viral VectorvGMAD000535Norway rat Pxdc1 Adenovirus particle
    ORF Viral VectorvGMLPm001292mouse Pxdc1 Lentivirus particle


    Target information

    Target IDGM-IP2684
    Target NamePXDC1
    Gene ID221749,66895,361238,722937,608512,101084361,613986,100058493
    Gene Symbol and Synonyms1300014I06Rik,C23H6orf145,C35H6orf145,C6orf145,PXDC1,RGD1311307
    Uniprot AccessionQ5TGL8,Q4KLK8,Q08D85
    Uniprot Entry NamePXDC1_HUMAN,PXDC1_RAT,PXDC1_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000168994
    Target ClassificationN/A

    The target: PXDC1, gene name: PXDC1, also named as C6orf145. Predicted to enable phosphatidylinositol binding activity. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.